Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Endothelial Cells Harbouring the JAK2V617F Mutation Display Pro-Adherent and Pro-Thrombotic Features
Anna Guadall, Élodie Lesteven, Gil Letort, et al.
Thrombosis and Haemostasis (2018) Vol. 118, Iss. 09, pp. 1586-1599
Closed Access | Times Cited: 73

Showing 1-25 of 73 citing articles:

Cardiovascular Risk in Philadelphia-Negative Myeloproliferative Neoplasms: Mechanisms and Implications—A Narrative Review
Samuel Bogdan Todor, Cristian Ichim, Adrian Boicean, et al.
Current Issues in Molecular Biology (2024) Vol. 46, Iss. 8, pp. 8407-8423
Open Access | Times Cited: 19
Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis
Virginia Hernández‐Gea, Andrea De Gottardi, Frank W.G. Leebeek, et al.
Journal of Hepatology (2019) Vol. 71, Iss. 1, pp. 175-199
Open Access | Times Cited: 106
Thromboembolic events in polycythemia vera
Martin Grießhammer, Jean‐Jacques Kiladjian, Carlos Besses
Annals of Hematology (2019) Vol. 98, Iss. 5, pp. 1071-1082
Open Access | Times Cited: 105
The pathobiology of thrombosis, microvascular disease, and hemorrhage in the myeloproliferative neoplasms
Hans Carl Hasselbalch, Margitta Elvers, Andrew I. Schafer
Blood (2021) Vol. 137, Iss. 16, pp. 2152-2160
Open Access | Times Cited: 70
JAK-STAT inhibition reduces endothelial prothrombotic activation and leukocyte–endothelial proadhesive interactions
Joan D. Beckman, Angelica DaSilva, Elena L. Aronovich, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 21, Iss. 5, pp. 1366-1380
Open Access | Times Cited: 27
Portal Vein Thrombosis: State-of-the-Art Review
Andrea Boccatonda, Simone Gentilini, Elisa Zanata, et al.
Journal of Clinical Medicine (2024) Vol. 13, Iss. 5, pp. 1517-1517
Open Access | Times Cited: 16
Endothelial Damage in JAK2V617F Myeloproliferative Neoplasms with Splanchnic Vein Thrombosis
Blanca De Moner, Julia Martínez-Sánchez, Marta Garrote, et al.
Thrombosis and Haemostasis (2025)
Closed Access | Times Cited: 1
Clinical insights into the origins of thrombosis in myeloproliferative neoplasms
Alison R. Moliterno, Yelena Ginzburg, Ronald Hoffman
Blood (2020) Vol. 137, Iss. 9, pp. 1145-1153
Open Access | Times Cited: 69
Thrombotic, inflammatory, and HIF-regulated genes and thrombosis risk in polycythemia vera and essential thrombocythemia
Radhika Gangaraju, Jihyun Song, Soo Jin Kim, et al.
Blood Advances (2020) Vol. 4, Iss. 6, pp. 1115-1130
Open Access | Times Cited: 62
Progression of Myeloproliferative Neoplasms (MPN): Diagnostic and Therapeutic Perspectives
Julian Baumeister, Nicolas Chatain, Alexandros Marios Sofias, et al.
Cells (2021) Vol. 10, Iss. 12, pp. 3551-3551
Open Access | Times Cited: 47
Platelets as Mediators of Thromboinflammation in Chronic Myeloproliferative Neoplasms
Cecilia P. Marín Oyarzún, Paula G. Heller
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 53
Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms
Alexandre Guy, Geoffrey Garcia, Virginie Gourdou-Latyszenok, et al.
Journal of Thrombosis and Haemostasis (2023) Vol. 22, Iss. 1, pp. 172-187
Closed Access | Times Cited: 15
Red Blood Cell Contribution to Thrombosis in Polycythemia Vera and Essential Thrombocythemia
Julien M. P. Grenier, Wassim El Nemer, Maria De Grandis
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1417-1417
Open Access | Times Cited: 5
Thromboinflammation in Myeloproliferative Neoplasms (MPN)—A Puzzle Still to Be Solved
Vikas Bhuria, Conny K. Baldauf, Burkhart Schraven, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 6, pp. 3206-3206
Open Access | Times Cited: 21
Distinct clinico-molecular arterial and venous thrombosis scores for myeloproliferative neoplasms risk stratification
Hélène Pasquer, Rafael Daltro De Oliveira, Loïc Vasseur, et al.
Leukemia (2023) Vol. 38, Iss. 2, pp. 326-339
Closed Access | Times Cited: 12
Exacerbation of thrombo-inflammation by JAK2V617F mutation worsens the prognosis of cerebral venous sinus thrombosis
Marie‐Charlotte Bourrienne, Véronique Le Cam Duchez, Dorothée Faille, et al.
Blood Advances (2024) Vol. 8, Iss. 12, pp. 3330-3343
Open Access | Times Cited: 4
Addressing and proposing solutions for unmet clinical needs in the management of myeloproliferative neoplasm-associated thrombosis: A consensus-based position paper
Tiziano Barbui, Valerio De Stefano, Anna Falanga, et al.
Blood Cancer Journal (2019) Vol. 9, Iss. 8
Open Access | Times Cited: 31
Endothelial JAK2V617F mutation leads to thrombosis, vasculopathy, and cardiomyopathy in a murine model of myeloproliferative neoplasm
Melissa Castiglione, Yaping Jiang, Christopher Mazzeo, et al.
Journal of Thrombosis and Haemostasis (2020) Vol. 18, Iss. 12, pp. 3359-3370
Open Access | Times Cited: 29
Splanchnic vein thrombosis associated with myeloproliferative neoplasms
Douglas Tremblay, Adam C. Winters, Joan D. Beckman, et al.
Thrombosis Research (2022) Vol. 218, pp. 8-16
Closed Access | Times Cited: 17
Myeloproliferative neoplasms and splanchnic vein thrombosis: Contemporary diagnostic and therapeutic strategies
Jean‐Jacques Kiladjian, Bruno Cassinat
American Journal of Hematology (2023) Vol. 98, Iss. 5, pp. 794-800
Open Access | Times Cited: 10
Protein disulfide isomerase in Philadelphia-negative myeloproliferative neoplasms: a case–control study
Marwa Salah Mohammed, Alaa Alnaggar, Nehad M. Tawfik, et al.
The Egyptian Journal of Internal Medicine (2025) Vol. 37, Iss. 1
Open Access
Coronary microcirculation in myocardial ischemia: A genetic perspective
Paolo Severino, Andrea D’Amato, Silvia Prosperi, et al.
Journal of Molecular and Cellular Cardiology (2025)
Closed Access
Molecular predictors of venous and arterial thrombotic events in patients with myelofibrosis
Olga Morath, Jenny Rinke, Andrew J. Walter, et al.
Annals of Hematology (2025)
Open Access
Vasculogenic Stem and Progenitor Cells in Human: Future Cell Therapy Product or Liquid Biopsy for Vascular Disease
David M. Smadja
Advances in experimental medicine and biology (2019), pp. 215-237
Closed Access | Times Cited: 28
Pathogenesis of cardiovascular events in BCR-ABL1-negative myeloproliferative neoplasms
Alexandre Guy, Johanne Poisson, Chloé James
Leukemia (2021) Vol. 35, Iss. 4, pp. 935-955
Closed Access | Times Cited: 23
Page 1 - Next Page

Scroll to top